Name: Clinical trials back cognition supplement efficacy
Uploaded: 2020-01-30T00:00:00+00:00
Duration: 4 min 12 s
Description: Nexira’s cognitive health supplement Cognivia has been on the market for a few years. Now, new clinical trials demonstrate how it is efficient one hour after intake and will last six to eight hours. The trials will be released in the next few months, Stefan-Emil Sitaru, Sales Manager Health Division at Nexira, details at Food Matters Live 2019 in London, UK.

Industry news
Industry news
All news
Business
Food ingredients
New product development
Packaging & processing
Personal care & cosmetics
Policy & regulation
Research & science
Tech & innovation
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort
Category news
Category news
Bone & joint health
Brain & mental health
Child nutrition
Delivery formats
Food security
Gut health
Heart health
Immunity
Infant nutrition
Men's health
Nutraceuticals
Oral & eye health
Personalized nutrition
Pet nutrition
Skin & beauty
Sports nutrition
Supplements
Weight management
Women's health
Reports
Reports
Key interviews
Special reports
Technical papers
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort
Key trends
Key trends
All key trends
Trend analysis
Nutrition focus
Product innovation
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort
Multimedia
Multimedia
All multimedia
Videos
Webinars
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort
Journal
Journal
Access all EditionsNEW
Advertising options
Subscribe now
Editorial enquiries
Latest editions
Dairy’s New Value
Snacks for Impact
Supplements for Everyday Vitality
Souped-Up Flavors
Events
Events
Event listing
Event previews
Event reviews
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort
Suppliers
Suppliers
Supplier profiles
Trending now
Suppliers warn GLP-1 companion category risks credibility gap without evidence
IFF backs probiotic strain quality over CFU counts, taps biomics to predict behavior
IFF report maps GLP-1 eating moments from protein-first mornings to evening comfort

Novonesis early life nutrition banner featuring a smiling baby with the message “Ready for a lifetime,” highlighting infant health and development.

Novonesis banner featuring a smiling woman and the message “More life to your years,” promoting science-backed solutions for healthy longevity

Home

Videos

Clinical trials back...

Clinical trials back cognition supplement efficacy

30 Jan 2020 | Nexira

Nexira’s cognitive health supplement Cognivia has been on the market for a few years. Now, new clinical trials demonstrate how it is efficient one hour after intake and will last six to eight hours. The trials will be released in the next few months, Stefan-Emil Sitaru, Sales Manager Health Division at Nexira, details at Food Matters Live 2019 in London, UK.

More videos

Video04:24

SupplySide Global 2026: Bactolife’s Helm binding proteins block harmful gut compounds

Bactolife CEO Sebastian Søderberg and co-founder and chief scientific officer Dr. Sandra Wingaard Thrane discuss Helm binding proteins, a novel gut health approach. Unlike probiotics, which introduce beneficial bacteria, or...

Video06:02

SupplySide Global 2026: ADM and Morinaga explore microbiome innovations and the future of gut health

At SupplySide Global 2026, ADM’s Divya Mohan, director of Global Food and Beverage Creation, Design and Development, and Health and Wellness, explored the emerging potential of phagebiotics, their role in the microbiome and...

Video06:48

SupplySide Global 2026: Givaudan targets metabolic health with Ayurvedic botanical Novaberin

Givaudan has launched Novaberin, a patent-pending botanical made from standardized extracts of two Ayurvedic botanicals, barberry and amla, at SupplySide Global 2026. Brian Appell, the company’s marketing manager of Nutra &...

Video04:57

CPHI Milan 2026: Natix backs microencapsulated enzymes for digestive and metabolic health

Stefaan Vandaele, CEO of Natix, noted that demand for plant- and animal-derived enzymes is rising, driven by interest in bioactives and the clean label trend — yet functionality remains essential. He highlighted the scientific...

Video08:56

CPHI Milan 2026: Cargill targets children and seniors with better-tasting, low-impurity excipients

Cargill’s Eelco van Oosterbosch, marketing director for Health and Nutrition, and Catherine Boghmans, senior applications specialist, highlighted the overlaps and differences between pharmaceutical ingredients and dietary...

Video09:15

CPHI Milan 2026: Indena champions biology over trends in delivery format choice

Stefano Togni, chief commercial officer at Indena, discussed how the industry is at the intersection of botanical science, delivery formats, and pharmaceutical rigor applied to nutraceuticals. He underscored that the biology of...